Table 1
DNA prevalence of B19, VZV, and HHV-6 in TAB specimens of patients with GCA and in control group
GCA (n = 57)
CG* (n = 56)
p
Results are shown as No (%).
*CG, control group
B19
31 (54)
21 (38)
0.07
HHV-6
20 (35)
19 (34)
0.89
VZV
18 (32)
18 (32)
0.94